Although IL-2 has been used to augment immune responses to treat cancer [6] and persistent viral infections [7], it also effectively suppressed immune responses in chronic graft-versus-host disease [8] and hepatitis C virus-induced vasculitis [9]. Here, IL2 is linked to chronic graft versus host disease.